Trial intelligence / Profile preview

Thiamine and eGFR in Type 2 Diabetes with CKD Stage 3

TCTR20200215004Phase 4Completed

Sponsor
Khon Kaen Hospital
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of thiamine in type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), sponsored by Khon Kaen Hospital. Started Jul 2017; status: completed.

02

Drugs

thiamine
03

Conditions

type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)

Beyond the preview

Go deeper on TCTR20200215004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200215004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call